Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

Nature Medicine

Volumn 9, Issue 7, 2003, Pages 936-943

  Autiero, Monica ^a   Waltenberger, Johannes ^b   Communi, Didier ^a   Kranz, Andrea ^b   Moons, Lieve ^a   Lambrechts, Diether ^a   Kroll, Jens ^b   Plaisance, Stephane ^a   De Mol, Maria ^a   Bono, Françoise ^c   Kliche, Stefanie ^b   Fellbrich, Guido ^b   Ballmer Hofer, Kurt ^d   Maglione, Domenico ^e   Mayr Beyrle, Ulrike ^b   Dewerchin, Mieke ^a   Dombrowski, Saskia ^b   Stanimirovic, Danica ^f   Van Hummelen, Paul ^a   Dehio, Christoph ^g   Hicklin, Daniel J ^h   Persico, Graziella ⁱ   Herbert, Jean Marc ^c   Communi, David ^j   Shibuya, Masabumi ^k   Collen, Désiré ^a   Conway, Edward M ^a   Carmeliet, Peter ^a   more..

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c SANOFI   (France)

^d PAUL SCHERRER INSTITUTE   (Switzerland)

^e Geymonat SpA   (Italy)

^f NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^g UNIVERSITY OF BASEL   (Switzerland)

^h ELI LILLY AND COMPANY   (United States)

ⁱ INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^j FREE UNIVERSITY OF BRUSSELS   (Belgium)

^k UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; DECORIN; EARLY GROWTH RESPONSE FACTOR 1; FOLLISTATIN; GROWTH FACTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NEUROPILIN 2; PLACENTAL GROWTH FACTOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CAPILLARY ENDOTHELIUM; CELL CYCLE; CONTROLLED STUDY; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; PRIORITY JOURNAL; RECEPTOR UPREGULATION; WESTERN BLOTTING;

ANIMALS; CELLS, CULTURED; DIMERIZATION; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MICE; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PREGNANCY PROTEINS; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTORS; VIRAL PROTEINS;

JANUS;

EID: 0037703184     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm884     Document Type: Article

References (46)

1. Rivard, A. et al. Age-dependent impairment of angiogenesis. Circulation 99, 111-120 (1999).
2. -/- mice. Circulation 99, 3188-3198 (1999).
3. Waltenberger, J. Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc. Res. 49, 554-560 (2001).
4. De Falco, S., Gigante, B. & Persico, M. Structure and function of placental growth factor. Trends Cardiovasc. Med, 12, 241-246 (2002).
5. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211-225 (2000).
6. Ferrara, N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis, Am. J. Physiol. Cell. Physiol. 280, C1358-C1366 (2001).
7. Park, J.E., Chen, H.H., Winer, J., Houck, K.A. & Ferrara, N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269, 25646-25654 (1994).
8. Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. & Shibuya, M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl. Acad. Sci. USA 95, 9349-9354 (1998).
9. Hiratsuka, S. et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. Cancer Res. 61, 1207-1213 (2001).
10. Luttun, A. et al. Revascularization of ischemic tissues by PIGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8, 831-840 (2002).
11. Zeng, H., Dvorak, H.F. & Mukhopadhyay, D. VPF/VEGF receptor-1 down-modulates VPF/VEGF receptor-2 mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase dependent pathways. J. Biol. Chem. 276, 26969-26979 (2001).
12. Zeng, H., Zhao, D. & Mukhopadhyay, D. Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1. J. Biol. Chem. 277, 4003-4009 (2002).
13. Gille, H. et al. A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits vascular endothelial growth factor-dependent phosphatidylinositol 3′-kinase activation and endothelial cell migration. EMBO J. 19, 4064-4073 (2000).
14. Yang, S. et al. Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells. Relative roles of KDR and Flt-1 receptors. Arterioscler. Thromb. Vasc. Biol. 22, 1797-1803 (2002).
15. Rahimi, N., Dayanir, V. & Lashkari, K. Receptor chimeras indicate that the VEGFR-1 modulates mitogenic activity of VEGFR-2 in endothelial cells. J. Biol. Chem. 275, 16986-16992 (2000).
16. Kanno, S. et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 19, 2138-2146 (2000).
17. Carmeliet, P. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583 (2001).
18. Adini, A., Kornaga, T., Firoozbakht, F. & Benjamin, L.E. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res. 62, 2749-2752 (2002).
19. Odorisio, T. et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J. Cell Sci. 115, 2559-2567 (2002).
20. Hattori, K. et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFRI(+) stem cells from bone-marrow microenvironment. Nat. Med. 8, 841-849 (2002).
21. Castellon, R. et al. Effects of angiogenic growth factor combinations on retinal endothelial cells. Exp. Eye Res. 74, 523-535 (2002).
22. Kendall, R.L., Wang, G. & Thomas, K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226, 324-328 (1996).
23. Huang, K., Andersson, C., Roomans, G.M., Ito, N. & Claesson-Welsh, L. Signaling properties of VEGF receptor-1 and -2 homo- and heterodimers. Int. J. Biochem. Cell Biol. 33, 315-324 (2001).
24. Cao, Y., Linden, P., Shima, D., Browne, F. & Folkman, J. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J. Clin. Invest. 98, 2507-2511 (1996).
25. DiSalvo, J. et al. Purification and characterization of a naturally occurring vascular endothelial growth factor placenta growth factor heterodimer. J. Biol. Chem. 270, 7717-7723 (1995).
26. Eriksson, A. et al. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PGF-1/VEGF heterodimers. Cancer Cell 1, 99-108 (2002).
27. Takahashi, T., Yamaguchi, S., Chida, K. & Shibuya, M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J. 20, 2768-2778 (2001).
28. Li, B. et al. Receptor-selective variants of human vascular endothelial growth factor. Generation and characterization, J. Biol. Chem. 275, 29823-29828 (2000).
29. Yu, Y. et al. Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3′-kinase binding. Biochem. J. 358, 465-472 (2001).
30. Igarashi, K. et al. Tyrosine 1213 of Flt-1 is a major binding site of Nck and SHP-2. Biochem. Biophys. Res. Commun. 246, 95-99 (1998).
31. Ito, N., Wernstedt, C., Engstrom, U. & Claesson-Welsh, L. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules. J. Biol. Chem. 273, 23410-23418 (1998).
32. Ito, N., Huang, K. & Claesson-Weish, L. Signal transduction by VEGF receptor-1 wild type and mutant proteins. Cell Signal. 13, 849-854 (2001).
33. Heymans, S. et al. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 5, 1135-1142 (1999).
34. Thuringer, D., Maulon, L. & Frelin, C. Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells. J. Biol. Chem. 277, 2028-2032 (2002).
35. Lowes, V.L., Ip, N.Y. & Wong, Y.H. Integration of signals from receptor tyrosine kinases and G protein-coupled receptors. Neurosignals 11, 5-19 (2002).
36. Wang, Y. et al. Interplay between integrins and FLK-1 in shear stress-induced signaling. Am. J. Physiol. Cell. Physiol. 283, C1540-C1547 (2002).
37. Gingras, D., Lamy, S. & Beliveau, R. Tyrosine phosphorylation of the vascular endothelial-growth-factor receptor-2 (VEGFR-2) is modulated by Rho proteins. Biochem. J. 348, 273-280 (2000).
38. Carmeliet, P. et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
39. Davis-Smyth, T., Presta, L.G. & Ferrara, N. Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability. J. Biol. Chem. 273, 3216-3222 (1998).
40. Cunningham, S.A., Arrate, M.P., Brock, T.A. & Waxham, M.N. Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites. Biochem. Biophys. Res. Commun. 240, 635-639 (1997).
41. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1993).
42. Wiesmann, C. et al. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91, 695-704 (1997).
43. Iyer, S. et al. The crystal structure of human placenta growth factor-1 (PGF-1), an angiogenic protein, at 2.0 A resolution. J. Biol. Chem. 276, 12153-12161 (2001).
44. Landgren, E., Schiller, P., Cao, Y. & Claesson-Welsh, L. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1. Oncogene 16, 359-367 (1998).
45. Shevchenko, A., Wilm, M., Vorm, O. & Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850-858 (1996).
46. Puskas, L.G., Zvara, A., Hackler, L., Jr. & Van Hummelen, P. RNA amplification results in reproducible microarray data with slight ratio bias, Biotechniques 32, 1330-1334 (2002).